Rapid Therapeutic Science Laboratories (RTSL) 10-Q2021 Q1 Quarterly report

Filed: 13 Aug 20, 2:13pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: absent, accumulated, accuracy, accurate, achieved, active, activity, adverse, adversely, aerosol, analyst, anticipate, anticipated, applied, arising, assurance, assure, ASU, August, awarded, aware, bid, Black, brought, bundle, Buyer, campaign, capture, cautionary, caveat, CEO, CFO, Chairman, claim, closely, closing, combat, communicated, contacted, contemplated, context, contractual, customer, deal, declared, derivative, direct, discount, disease, distinct, documentation, Donal, duration, duty, Earlier, eighty, encouraged, entitled, eventually, evidence, evidencing, expressed, fair, FASB, fifteen, Finally, foregoing, foreseeable, founder, gathered, governmental, gradually, greater, guarantee, hand, heading, health, high, hundred, identical, implied, indirectly, intend, intercompany, Inventory, investor, Jr, leading, legend, Lending, line, loan, local, location, lowest, measure, measurement, memorandum, minimal, model, observable, offset, ongoing, online, oral, originally, outbreak, page, pertinent, physical, point, portal, precise, president, private, proceeding, procuring, profit, project, promise, promised, prove, proxy, publicly, rapidly, Reform, refunded, reliability, reliable, reliance, rely, represent, resale, response, restricted, retail, review, revise, revised, robust, RTSL, Schmidt, seasonality, separate, Separately, service, shortage, site, space, sporadic, standalone, standard, Statement, strain, subscription, summarized, supplemented, telephone, terminology, therefrom, thin, trade, trading, ultimately, uncommon, undue, unknown, unobservable, update, valuation, vary, volume, wholesale, working, worldwide, written, Wuhan

Removed: ASC, coverage, emerging, entirety, federal, growth, July, lease, property, qualified, rent, repairing, step

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

RTSL similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Rapid Therapeutic Science Laboratories, Inc. (the “registrant”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Donal R. Schmidt, Jr., Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

/s/Donal R. Schmidt, Jr.

Donal R. Schmidt, Jr.

Chief Executive Officer

August 13, 2020

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.